FDA
-
-
-
-
-
-
-
FDA accepts Takeda drug application for narcolepsy treatment
-
-
-
-
-
-
-
US FDA investigates Takeda's blood disorder drug after pediatric death
-
-
-
-
-
-
-
Innovent Biologics Announces Global Strategic Partnership with Takeda to Bring Innovent's Next Gen IO Backbone Therapy and ADC Molecules to the Global Market
-
-
-
-
-
-
-
Takeda Receives FDA 510(k) Clearance for HyHubTM and HyHubTM Duo Devices to Simplify HYQVIA® Administration
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Takeda Pharmaceutical (TAK) Ahead of 'Key Upcoming Readouts'
-
-
-
-
-
-
-
Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
-
-
-
-
-
-
-
Takeda (TAK) Receives EU Approval for FRUZAQLA
-
322,881 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

